Evidence map›Paper›PMID 40062815›Full record

ArticleInvestigative ophthalmology & visual science2025

Artificial Intelligence Versus Rules-Based Approach for Segmenting NonPerfusion Area in a DRCR Retina Network Optical Coherence Tomography Angiography Dataset.

Tristan T Hormel, Wesley T Beaulieu, Jie Wang, Jennifer K Sun, Yali Jia

Abstract readComparative StudyMulticenter Study
In one paragraph

Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tristan T HormelOregon Health and Science University, Portland, Oregon, United States.
Wesley T BeaulieuJaeb Center for Health Research, Tampa, Florida, United States.
Jie WangOregon Health and Science University, Portland, Oregon, United States.
Jennifer K SunJoslin Diabetes Center, Beetham Eye Institute, Harvard Department of Ophthalmology, Boston, Massachusetts, United States.
Yali JiaOregon Health and Science University, Portland, Oregon, United States.

Funding

Proteomics CoreP30EY010572 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI KIRSTEN Jeanne LAMPI · 1995 to 2026
$19.4M
OCT Angiography for Neovascular Age-related Macular DegenerationR01EY024544 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Steven T Bailey, Yali Jia · 2014 to 2026
$6.2M
OCTA Precursors of Vision-Threatening Complications of Diabetic RetinopathyR01EY035410 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Thomas Hwang, Yali Jia · 2023 to 2026
$2.5M
Translational Vision Science Research at Oregon Health & Science UniversityT32EY023211 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Yali Jia, Kate E Keller · 2013 to 2026
$2.4M
Advancing visible-light OCT in oxygen-induced retinopathyR01EY036429 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI John Peter Campbell, Yali Jia · 2024 to 2026
$2.0M
Wide-field and projection-resolved optical coherence tomography angiography in diabetic retinopathyR01EY027833 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI HWANG, THOMAS, JIA, YALI · 2017 to 2020
$1.8M
Visible-light OCT angiography, velocimetry, and oximetry for characterizing retinal vascular alterations in glaucomaR01EY031394 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI JIA, YALI, MORRISON, JOHN C · 2020 to 2022
$1.6M
Functional Optical Coherence Tomography-derived Biomarkers for Diabetic RetinopathyDP3DK104397 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI JIA, YALI, WILSON, DAVID J · 2014 to 2014
$1.0M
A diagnostic platform for diabetic retinopathy based on OCT angiography and artificial intelligenceR43EY036781 · NEI · IFOCUS IMAGING LLC · PI HORMEL, TRISTAN, JIA, YALI · 2024 to 2024
$306k
NEI NIH HHS P30 EY010572NEI NIH HHS R01 EY024544NEI NIH HHS R01 EY027833NEI NIH HHS R01 EY031394NEI NIH HHS R01 EY035410NEI NIH HHS R01 EY036429NEI NIH HHS R43 EY036781NEI NIH HHS T32 EY023211NIDDK NIH HHS DP3 DK104397
6 · The paper itself

Abstract

Purpose: Loss of retinal perfusion is associated with both onset and worsening of diabetic retinopathy (DR). Optical coherence tomography angiography is a noninvasive method for measuring the nonperfusion area (NPA) and has promise as a scalable screening tool. This study compares two optical coherence tomography angiography algorithms for quantifying NPA. Methods: Adults with (N = 101) and without (N = 274) DR were recruited from 20 U.S. sites. We collected 3 × 3-mm macular scans using an Optovue RTVue-XR. Rules-based (RB) and deep-learning-based artificial intelligence (AI) algorithms were used to segment the NPA into four anatomical slabs. For comparison, a subset of scans (n = 50) NPA was graded manually. Results: The AI method outperformed the RB method in intersection over union, recall, and F1 score, but the RB method has better precision relative to manual grading in all anatomical slabs (all P ≤ 0.001). The AI method had a stronger rank correlation with Early Treatment of Diabetic Retinopathy Study DR severity than the RB method in all slabs (all P < 0.001). NPAs graded using the AI method had a greater area under the receiver operating characteristic curve for diagnosing referable DR than the RB method in the superficial vascular complex, intermediate capillary plexus, and combined inner retina (all P ≤ 0.001), but not in the deep capillary plexus (P = 0.92). Conclusions: Our results indicate that output from the AI-based method agrees better with manual grading and can better distinguish between clinically relevant DR severity levels than a RB approach using most plexuses.

Indexed as

Artificial IntelligenceDiabetic RetinopathyFluorescein AngiographyRetinal VesselsTomography, Optical CoherenceAdultAgedAlgorithmsDeep LearningFemaleFundus OculiHumansMaleMiddle AgedROC Curve

Identifiers

PMID40062815
PMCPMC11905605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.